Zentalis Pharmaceuticals Llc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +117.6% | +44.1% | +240.0% | +162.1% | -2.6% | -7.2% | -42.7% | |
| – | +100.3% | +3,651.4% | +54.4% | +31.1% | +17.0% | +22.7% | -69.2% | |
| – | -131.8% | – | +101.6% | +34.6% | – | – | – | |
| – | – | +20.5% | +111.7% | -20.2% | -55.8% | -382.1% | – | |
| – | +55.1% | +115.3% | +705.7% | -58.3% | -77.1% | -62.1% | -100.0% | |
| – | +55.1% | +80,818.2% | -93.6% | +530.3% | -61.1% | – | -25.5% | |
| – | +764.4% | +322.8% | -100.0% | – | -100.0% | – | – | |
| – | +763.9% | +340.5% | -50.5% | +46.2% | -9.1% | -100.0% | -4,064.8% | |
| – | – | -126.5% | – | -367.5% | – | – | -64.0% | |
| – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.